Eupraxia Pharmaceuticals (EPRX) Accounts Payables (2022 - 2026)
Eupraxia Pharmaceuticals' Accounts Payables came in at $8.39 million for the quarter ended Jun 30, 2026, up 224.8% from $2.58 million a year earlier and up 17.2% from the prior quarter.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Accounts Payables (2022 - 2026) Analysis & Trends
As of Dec 31, 2025, Eupraxia Pharmaceuticals' Accounts Payables was $5.55 million, up 83.1% from the prior year.
- Accounts Payables carries a three-year compound annual growth rate of 23.7% (years ended Dec 2022 to Dec 2025).
- Going back by year, Accounts Payables was $3.03 million in the year ended Dec 31, 2024 (-22.7%), $3.92 million in the year ended Dec 31, 2023 (+33.9%) and $2.93 million in the year ended Dec 31, 2022.
- The figure for the quarter ended Jun 30, 2026 represents the highest quarterly Accounts Payables in data going back to the quarter ended Dec 31, 2022.
- Year-over-year, Accounts Payables has increased for five consecutive quarters, with growth averaging 80.9% over the last seven quarters.
- The fastest year-over-year change in Accounts Payables over five years came in the quarter ended Mar 31, 2026 (growth of 233.4%), and the weakest in the quarter ended Mar 31, 2025 (a decline of 45.9%).
- Business Quant data shows EPRX's Accounts Payables at $7.16 million (quarter ended Mar 31, 2026), $5.55 million (quarter ended Dec 31, 2025) and $3.73 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Eupraxia Pharmaceuticals | 332.04 Mn | 330.43 Mn | - | 8.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.39 Mn |
| Mar 31, 2026 | 7.16 Mn |
| Dec 31, 2025 | 5.55 Mn |
| Sep 30, 2025 | 3.73 Mn |
| Jun 30, 2025 | 2.58 Mn |
| Mar 31, 2025 | 2.15 Mn |
| Dec 31, 2024 | 3.03 Mn |
| Sep 30, 2024 | 2.29 Mn |
| Jun 30, 2024 | 1.98 Mn |
| Mar 31, 2024 | 3.97 Mn |
| Dec 31, 2023 | 3.92 Mn |
| Dec 31, 2022 | 2.93 Mn |
API Access
Eupraxia Pharmaceuticals Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();